FDA Gives Spectranetics ’ Recall Class I Status
FDA has decided that Spectranetics’ recent recall of its Bridge Occlusion Balloon Catheter deserves Class I status. The company sent an urgent letter to customers and distributors in August to alert them of a recall involving the Bridge Occlusion Balloon Catheter after nine customers complained about blocked guidewire lumens.
Spectranetics said none of the compromised devices caused any serious injury to the patient, but the company’s inspection revealed that the frequency of a potentially blocked guidewire lumen is about 10%. If a device with a compromised guidewire lumen were to be used, the company said...
Source: MDDI - September 26, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Regulatory and Compliance Source Type: news
Architecture CEO talks merger with New York firm, Houston health care trends
"The whole health care landscape is really being exposed to truly disruptive innovation." (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 25, 2017 Category: American Health Authors: Cara Smith Source Type: news
Contraception Is about Partnerships —in More Ways than One
September 25, 2017To make family planning work for young people, we need to look at the bigger picture.Imagine you are very, very poor. You and your family have, say, $100 or less for the entire month. What are your priorities?For most people, the main concerns would be food, safe drinking water, shelter, and maybe education, if there ’s anything left over. When you’re making decisions under this type of pressure, a lot of important things fall to the bottom of the list.Contraception is one of them.In the global health community, we call the hardships that dog impoverished families “economic barriers.&rdq...
Source: IntraHealth International - September 25, 2017 Category: International Medicine & Public Health Authors: mnathe Source Type: news
Shandong Weigao to pay $850m for Argon Medical Devices
Shandong Weigao Group Medical Polymer agreed to pay $850 million for Argon Medical Devices, as the Chinese company looks to expand its footprint overseas.
Weigao Group, which makes medical devices, orthopedic and blood purification products, is trying to fill out its product portfolio and diversify its revenue stream, according to a filing with the Hong Kong Stock Exchange. The company said it expects “significant growth opportunities” for Argon Medical’s products in China, according to the filing.
Plano, Texas-based Argon Medical makes single-use speciality medical devices for biopsy, vascular ...
Source: Mass Device - September 25, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Wall Street Beat Argon Medical Devices Inc. Shandong Weigao Group Medical Polymer Source Type: news
John Oliver Breaks Down Corporate Consolidation on Last Week Tonight
John Oliver wants you to know that small business is the backbone of our economy — and he has the eerily echoing footage of U.S. politicians to prove it. “It’s that rare thing that ever politician agrees on,” said Oliver. “It’s that, support our troops, Ted Cruz can go f— himself, and South Dakota Senator John Thune can get it.”
While small business is the backbone of the economy, these days, big business is getting bigger than ever thanks to mergers and acquisitions, which is what Oliver focused on during Sunday night’s episode of Last Week Tonight. Corporate consolida...
Source: TIME: Top Science and Health Stories - September 25, 2017 Category: Science Authors: Melissa Locker Tags: Uncategorized John Oliver Last Week Tonight Late Night Comedy Television Source Type: news
Smiths Group shares fall on missed forecast
Smiths Medical parent company Smiths Group (LON:SMIN) saw shares fall more than 5% today after reporting a fall in underlying full-year revenue due to weaknesses in its medical device unit and energy equipment and service businesses.
The fall made the company the worst performer on the London Stock Exchange’s FTSE 100 Index today.
Smiths Medical was faced with delays in its new product releases, seeing revenues decline 3% for the year at $1.28 billion (GBP £951 million), while analysts on Wall Street expected to see revenues of $1.3 billion (GBP £962 million).
Overall, the company’s revenu...
Source: Mass Device - September 22, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Smiths Group plc Smiths Medical Source Type: news
Boehringer Ingelheim beefs up St. Joe manufacturing after merger
After closing its mega-merger with Merial this year, Boehringer Ingelheim slowly began ramping up its animal health manufacturing in St. Joseph.
The company confirmed that it would increase production capacity as it transfers products from its former Fort Dodge, Iowa, facility. Elanco U.S. Inc. acquired the facility from Boehringer Ingelheim Animal Health in 2016, as well as a portfolio of its vaccine products, for $885 million as part of Boehringer Ingelheim’s acquisition of Merial.
The St.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news
Lightstone Ventures raises $250m second fund
Lightstone Ventures this week said it raised $250 million for its second fund, $50 million more than it was aiming for.
Menlo Park, Calif.- and Boston-based Lightstone said it plans to use the cash to back “companies developing therapies which have the potential to change the practice of medicine” and to found companies via its alliance with the Foundry medtech incubator and other strategic partners.
The second fund has already made an investment, joining the $30 million Series A round for pharma startup Disarm Therapeutics.
“The successful implementation of our strategy requires the ability to ident...
Source: Mass Device - September 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Wall Street Beat Lightstone Ventures Venture Capital/Private Equity Source Type: news
To Do: Join Forces, Save Lives
September 22, 2017Change is in the air. And it feels good.The secret is out! And we couldn ’t be more excited.After months of planning, strategizing, and daydreaming about how to reach more people around the world with the health care they need, we ’ve done something big:IntraHealth International is joining forces withDAI, one of the world ’s leading development organizations.If we want to keep doing good, we need to be creative about it.Our partnership issomething new, both for us and for the world of international development. It ’s not a merger. It’s not an acquisition. It’s a unique ...
Source: IntraHealth International - September 22, 2017 Category: International Medicine & Public Health Authors: mnathe Source Type: news
Appropriateness of different pedagogical approaches to road safety education for children with Developmental Coordination Disorder (DCD) - Purcell C, Romijn AR.
BACKGROUND: In 2016, 29% of pedestrians killed or seriously injured on the roads in Great Britain were under 15 years of age. Children with Developmental Coordination Disorder (DCD), a chronic disorder affecting the acquisition and execution of motor skill... (Source: SafetyLit)
Source: SafetyLit - September 22, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Cardinal Health inks distro deal with Avadim Tech
Life science company Avadim Technologies said yesterday it inked a deal withCardinal Health (NYSE:CAH) to distribute Avadim’s Theraworx topical bionome therapies designed to prevent catheter-associated urinary tract infections and complications.
The companies said that the Theraworx topical solution will compliment Cardinal Health’s Dover urological portfolio.
“We are honored to partner with one of the most influential leaders in healthcare across the globe. Cardinal Health’s commitment to improving healthcare for more people, in more ways, and in more places than ever before is directly aligne...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Urology Cardinal Health Source Type: news
MassDevice.com +5 | The top 5 medtech stories for September 20, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. The 10 largest medical device companies in the world
Mergers & acquisitions continue to change the medical device landscape, as reflected in Medical Design & Outsourcing’s new Big 100 list.
We pulled financial reg...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
CopperPoint pays $150M cash for California workers' comp carrier
Workers' comp acquisition boosts underwriting business to $400M for this Phoenix company (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 20, 2017 Category: American Health Authors: Angela Gonzales Source Type: news
The 10 largest medical device companies in the world
Mergers & acquisitions continue to change the medical device landscape, as reflected in Medical Design & Outsourcing’s new Big 100 list.
We pulled financial regulatory filings and reached out to major companies in some cases to create a list of the 100 largest medical device companies in the world, ranked by annual revenue for their medical device operations. Yesterday, we counted down Nos. 20–11. Today, it’s the top 10.
Read on to find out important information about medtech’s largest companies.
Download the full Big 100 list here.
And you can also pick up a free hard copy of the Big 100 is...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: Chris Newmarker Tags: Big Data Business/Financial News Big 100 Source Type: news
The 20 largest medical device companies in the world
When it comes to the largest medical device companies, it’s a changing cast of players – as demonstrated once again in Medical Design & Outsourcing’s latest Big 100 list.
We pulled financial regulatory filings and reached out to major companies in some cases to create a list of the 100 largest medical device companies in the world, ranked by annual revenue for their medical device operations. Now we’re going to count down the top 20.
Some companies are usual suspects, but there are also surprises – especially thanks to the continued frenzy of mergers and acquisitions taking place in the sp...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: Chris Newmarker Tags: Big Data Business/Financial News Big 100 Source Type: news
Stryker wins FDA 510(k) for 3D-printed Tritanium C anterior cervical cage
Stryker (NYSE:SYK) said today it won FDA 510(k) clearance for its Tritanium C 3D-printed anterior cervical cage interbody fusion cage desigend for cervical spinal use.
The newly cleared Tritanium C cage is constructed with the company’s Tritanium in-growth technology featuring a highly porous titanium material designed for bone ingrowth and biological fixation.
The company claims the porous structure of the material creates a favorable environment for cell attachment and proliferation, and has been verified by in-vitro studies.
“We are excited to introduce the Tritanium C anterior cervical cage following t...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Spinal Stryker Source Type: news
Essilor, Luxotica rebuff EU anti-trust regulators
(Reuters) –Luxottica (NYSE:LUX) and Essilor (EPA:EI) have not offered any concessions to allay EU antitrust regulators’ concerns over their proposed 46-billion-euro ($55.2 billion) merger, increasing the possibility of a lengthy EU investigation into the deal.
Italian eyewear maker Luxottica, which owns brands such as Ray-Ban and Oakley, and French lens manufacturer Essilor had until Sept. 19 to offer concessions after the EU competition enforcer expressed its reservations about the deal to the companies last week.
The European Commission recognises if the parties to a merger have made concession...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: MassDevice Tags: Business/Financial News Regulatory/Compliance Essilor Luxottica Source Type: news
Investors seek class action status in lawsuit over St. Jude implantable defib batteries
Abbott (NYSE:ABT) is facing an investor suit from an Alaskan union-benefits fund over allegations that St. Jude Medical, which it closed its acquisition of in January, failed to notify regulators about defective lithium batteries in its implantable defibrillators.
In the lawsuit, plaintiffs allege that St. Jude was informed of the battery defect “as early as 2011”, but it failed to take action and would wait 5 years before issuing a recall for the devices.
St. Jude received 42 product reports which showed “evidence of premature battery depletion due to lithium cluster bridging,” court documents...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Legal News Abbott stjudemedical Source Type: news
Nursing director ‘excited’ at prospect of future trust merger
A director of nursing has said she is positive about how the merger of her community trust with a nearby mental health provider will create “opportunities” to improve patient care. (Source: Nursing Times)
Source: Nursing Times - September 20, 2017 Category: Nursing Source Type: news
Trusts to appoint joint chief ahead of merger
A community trust and mental health trust have announced plans to merge and will switch to joint leadership next year. (Source: HSJ)
Source: HSJ - September 20, 2017 Category: UK Health Source Type: news
The Differences in Characteristics Among Households With and Without Obese Children: Findings From USDA's FoodAPS (September 2017)
Using data from USDA's 2012 National Household Food Acquisition and Purchase Survey (FoodAPS), this study examines characteristics of households with at least one obese child (obese-child households) and without any obese children (nonobese-child households) to understand potential reasons behind the dissimilar risks. (Source: HSR Information Central)
Source: HSR Information Central - September 20, 2017 Category: International Medicine & Public Health Source Type: news
Centinel Spine acquires Prodisc assets from J & J ’ s DePuy Synthes
Centinel Spine has agreed to acquire Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes’ Prodisc assets for an undisclosed amount, according to an OrthoWorld report.
In the deal, DePuy is offloading its Prodisc-C, Prodisc-L, Prodisc-C Vivo, Prodisc-C Nova, Prodisc-O and Discover cervical and lumbar artificial disc systems to Centinel Spine, according to the report.
The Prodisc-C and Prodisc-L are the only 2 products which have approval in the US, according to OrthoWorld, and Centinel plans to launch clinical studies as it pursues FDA approval of the other devices it acquired.
Centinel spine is ...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Spinal Centinel Spine LLC depuysynthes johnsonandjohnson Source Type: news
Acquisition of New York health insurer will not affect Albany jobs
An acquisition of one of New York's largest health insurers will not affect its more than 475 employees based in Albany, New York.
Fidelis Care, a nonprofit insurer based in Queens, announced last week it signed an agreement to sell most of its assets to St. Louis-based Centene Corp. (NYSE: CNC) for $3.75 billion.
The acquisition comes after the size of its Albany regional office has quadrupled over the past four years. Its Albany office, based at 31 British American Blvd. in Latham, has grown… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 19, 2017 Category: Biotechnology Authors: Shannon Sweeney Source Type: news
10 of the world ’s largest medical device companies
When it comes to the largest medical device companies, it’s a changing cast of players – as demonstrated once again in Medical Design & Outsourcing’s latest Big 100 list.
We pulled financial regulatory filings and reached out major companies to create a list of the 100 largest medical device companies in the world, ranked by annual revenue for their medical device operations. Now we’re going to count down the top 20, starting with Nos. 20–11 today.
Some companies are usual suspects, but there are also surprises – especially thanks to the continued frenzy of mergers and acquisitions t...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Chris Newmarker Tags: Big Data Business/Financial News 3m Abbott Alcon bbraun bbraunmedical Big 100 Novartis Olympus zimmerbiomet Source Type: news
Catalent dishes out $950m for biologics manufacturer
Catalent said today that it plans to purchase Cook Pharmica for $950 million in cash.
Cook Pharmica, a unit of privately-held medical device maker Cook Group, is a contract manufacturer that develops biologics-based drug compounds.
Get the full story at our sister site, Drug Delivery Business News.
The post Catalent dishes out $950m for biologics manufacturer appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Contract Manufacturing Mergers & Acquisitions Pharmaceuticals Wall Street Beat Catalent Source Type: news
CCGs rule out merger as 'unwelcome distraction'
Three clinical commissioning groups in Leicestershire have ruled out merging as it would be “an unwelcome distraction”. (Source: HSJ)
Source: HSJ - September 19, 2017 Category: UK Health Source Type: news
Crop Science Division of Bayer well positioned to fulfill future customer, market and societal needs
Global seed and crop protection market will continue to grow / Business in Brazil expected to return to normal in 2018 / Progress being made in planned Monsanto acquisition / Anticipated closing in early 2018 / Planned R&D investment of approximately EUR 1 billion in 2017 / R&D efforts to bring 15 new products to farmers between 2017 and 2020 / Strong focus on innovation and sustainability / Commitment to transparency (Source: Bayer Company News)
Source: Bayer Company News - September 19, 2017 Category: Pharmaceuticals Source Type: news
Crop Science Division of Bayer well positioned to fulfill future customer, market and societal needs
Global seed and crop protection market will continue to grow / Business in Brazil expected to return to normal in 2018 / Progress being made in planned Monsanto acquisition / Anticipated closing in early 2018 / Planned R&D investment of approximately EUR 1 billion in 2017 / R&D efforts to bring 15 new products to farmers between 2017 and 2020 / Strong focus on innovation and sustainability / Commitment to transparency (Source: Bayer Company News)
Source: Bayer Company News - September 19, 2017 Category: Pharmaceuticals Source Type: news
Landmark hospital merger to lead to major service reshuffle
A merger to create one of the country’s largest acute trusts will lead to some specialist services being shifted between hospitals, an NHS Improvement report reveals. (Source: HSJ)
Source: HSJ - September 19, 2017 Category: UK Health Source Type: news
Another extension for Abbott ’ s tender for Alere
Abbott (NYSE:ABT) today announced yet another extension of its tender offer for all outstanding Alere (NYSE:ALR) Series B convertible perpetual preferred shares at $402 per share, pushing the deadline from Sept. 15. to near the end of the month.
As part of the offering, Abbott said it will also pay for unpaid dividends to the settlement date of the tender offer in cash, without interest and subject to applicable taxes.
The offer, originally announced on July 17, is being extended to “allow additional time for the consummation of the merger,” Abbott said in a press release. The offe...
Source: Mass Device - September 18, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Diagnostics Mergers & Acquisitions Wall Street Beat Abbott Alere Source Type: news
H & H Medical Announces Acquisition of Rights to SWAT-T Tourniquet
H&H Medical Corporation, a leading provider of emergency trauma products, is proud to announce the acquisition of the right to produce the SWAT-T elastic tourniquet from TEMS Solutions, LLC. The addition of this product will expand H&H Medical’s line of “Stop The Bleed” products available to military and civilian customers worldwide.
The SWAT-T was developed by a former Operator/Medic with 14 years’ experience in Operational Medicine - former USAF Pararescue Journeyman (Para-Jumper or PJ), Contractor DoJ/FBI SWAT Operations, National Registry Paramedic, and Emergency Medicine Physician. The ...
Source: JEMS Patient Care - September 18, 2017 Category: Emergency Medicine Authors: H & H Medical Tags: Trauma Industry News Equipment & Gear Source Type: news
H & H Medical Announces Acquisition of Rights to SWAT-T Tourniquet
H&H Medical Corporation, a leading provider of emergency trauma products, is proud to announce the acquisition of the right to produce the SWAT-T elastic tourniquet from TEMS Solutions, LLC. The addition of this product will expand H&H Medical’s line of “Stop The Bleed” products available to military and civilian customers worldwide.
The SWAT-T was developed by a former Operator/Medic with 14 years’ experience in Operational Medicine - former USAF Pararescue Journeyman (Para-Jumper or PJ), Contractor DoJ/FBI SWAT Operations, National Registry Paramedic, and Emergency Medicine Physician. The ...
Source: JEMS Operations - September 18, 2017 Category: Emergency Medicine Authors: H & H Medical Tags: Trauma Industry News Equipment & Gear Source Type: news
Merger trust seeks to fix 'cultural' differences between managers and clinicians
Trust leaders have outlined plans to address “cultural” differences between clinicians and managers at Royal Manchester Children’s Hospital. (Source: HSJ)
Source: HSJ - September 18, 2017 Category: UK Health Source Type: news
HSJ Catch Up: Trust and STP mergers, a legal battle and flu warnings
Your essential update on health for the week (Source: HSJ)
Source: HSJ - September 15, 2017 Category: UK Health Source Type: news
Medtronic, Mazor Robotics close $40m round
Mazor Robotics (NSDQ:MZOR) said today that closed the third, $40 million tranche of a deal with Medtronic (NYSE:MDT), which is due to take on exclusive global distribution rights for the Mazor X robot-assisted surgery device.
It’s the third investment in the Israeli surgical robotics concern for Fridley, Minn.-based Medtronic, taking its total investment to $72 million, 10.6% stake in Mazor. The deal also includes 1.21 million warrants priced at $44.23 apiece; if exercised in full Medtronic would own a 14.2% stake in Mazor, having invested some $125 million.
Get the full story from ...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Robotics Wall Street Beat mazorrobotics Medtronic Source Type: news
M & As this week: inviCRO, Inotek Pharmaceuticals Corporation
inviCRO has completed the acquisition of UK-based translational research company Imanova. (Source: Drug Development Technology)
Source: Drug Development Technology - September 14, 2017 Category: Pharmaceuticals Source Type: news
Apple ’s New $1,000 iPhone X Is Luxuriously Out of Touch
You could be forgiven for seeing the iPhone as a functional and practical acquisition. The phone, after all, has revolutionized how we take pictures, order food, sign up for an exercise class, read the news, listen to music, communicate across thousands of miles through FaceTime and wait, as if reading tea leaves, as we watch the ellipses between exchanges with a new romantic partner. With each release of a new version, Apple makes its previous technology antiquated in mere seconds, thus shaming many of us to upgrade.
For millions of us, the many capabilities of the iPhone make dropping several hundred dollars to acquire o...
Source: TIME.com: Top Science and Health Stories - September 14, 2017 Category: Consumer Health News Authors: Elizabeth Currid-Halkett Tags: Uncategorized Class iPhone tech technology Source Type: news
Candy conglomerate Mars buys 800 animal hospitals for $9.1B, including 1 in the Triad
Mars Inc., like rival Nestle USA, is so much more than candy.
Virginia-based Mars on Sept. 12 announced its successful acquisition of VCA Inc. and its 800 small veterinary hospitals in the United States and Canada, its animal diagnostic imaging company and its doggy day care and overnight camp franchise, Camp Bow Wow. VCA has one location in the Memphis-area and five across the state.
Mars, one of the nation's largest privately held companies, paid $93 per share for VCA in a deal valued at $9.1… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 14, 2017 Category: Biotechnology Authors: Michael Neibauer Source Type: news
Centene's stock rises after Fidelis acquisition
The St. Louis-based health insurance provider is expanding into the New York market with the $3.75 billion deal (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 14, 2017 Category: Consumer Health News Source Type: news
Candy conglomerate Mars buys 800 animal hospitals for $9.1B, including 1 in Memphis-area
Mars Inc., like rival Nestle USA, is so much more than candy.
Virginia-based Mars on Sept. 12 announced its successful acquisition of VCA Inc. and its 800 small veterinary hospitals in the United States and Canada, its animal diagnostic imaging company and its doggy day care and overnight camp franchise, Camp Bow Wow. VCA has one location in the Memphis-area and five across the state.
Mars, one of the nation's largest privately held companies, paid $93 per share for VCA in a deal valued at $9.1… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 14, 2017 Category: Health Management Authors: Michael Neibauer Source Type: news
Department of Defense Kidney Cancer Research Program
The FY17 Defense Appropriations Act provides $10 million (M) to the Department of Defense Kidney Cancer Research Program (KCRP) to support United States Army Medical Research Acquisition Activity (USAMRAA). As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).09/30...
Source: Kidney Cancer Association - September 14, 2017 Category: Urology & Nephrology Source Type: news
A Tenet Healthcare Sale Could Draw Many Bidders
There could be many potential Tenet suitors from rival for-profit hospital chains like HCA Holdings or Community Health Systems to rivals in the outpatient care space like UnitedHealth Group ’s Optum unit, which is seeking acquisitions of to bolster its business. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 14, 2017 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:CYH NYSE:UNH NYSE:THC NYSE:HCA Source Type: news
LivaNova mulls sale for CRM biz
LivaNova (NSDQ:LIVN) said today that it’s considering a sale for its cardiac rhythm management business, tapping Barclays to shop the $250 million operation to potential buyers.
“As part of our ongoing efforts to position LivaNova for long-term success, we are sharpening our focus on the company’s areas of strength and market leadership. To that end, we are exploring options to realize the full value of the CRM Business Franchise,” CEO Damien McDonald said in prepare remarks. “The CRM business franchise is a global business and strong regional player with attractive assets, a robust pipel...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Mergers & Acquisitions Wall Street Beat Cardiac Rhythm Management LivaNova Source Type: news
HealthPartners to merge with Hutchsinon health care provider
HealthPartners Inc. will merge with a health care provider in Hutchinson, Minn., the organizations announced Wednesday.
Hutchinson Health, which runs a 66-bed hospital and clinics in southwest Minnesota, will retain its name and remain locally governed. The deal is expected to close in 2018.
The announcement comes about five years after Hutchinson Health formed through the merger of Hutchinson Area Health Care and Hutchinson Medical Center.
"We believe that the best care is delivered close to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 14, 2017 Category: Pharmaceuticals Authors: Katharine Grayson Source Type: news
MicroMass Communications joins Ashfield
MicroMass designs solutions across all therapeutic areas that improve patient and health outcomes by changing patient and provider behaviour. These solutions are created bespoke to the needs of each of MicroMass’ pharmaceutical clients. As the role of patients in healthcare decision making expands, coupled with the ongoing shift to digital channels, demand from pharmaceutical companies for behavioural change and direct patient engagement capabilities is increasing.
MicroMass generates the majority of its revenue from patient engagement and support programmes, with the remainder coming from HCP (healthcare professiona...
Source: Ashfield Healthcare News - September 14, 2017 Category: Pharmaceuticals Authors: Jane Neale Tags: Ashfield Source Type: news
Candy conglomerate Mars buys 800 animal hospitals for $9.1B, including 15 in Houston area
Mars Inc., like rival Nestle USA, is so much more than candy.
Virginia-based Mars on Sept. 12 announced its successful acquisition of VCA Inc. and its 800 small veterinary hospitals in the United States and Canada, its animal diagnostic imaging company and its doggy day care and overnight camp franchise, Camp Bow Wow. VCA has 15 locations in the Houston area and 54 across the state.
Mars, one of the nation's largest privately held companies, paid $93 per share for VCA (Nasdaq: WOOF) in a deal valued… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 14, 2017 Category: American Health Authors: Michael Neibauer Source Type: news
Candy conglomerate Mars buys 800 animal hospitals for $9.1B, including 15 in Houston area
Mars Inc., like rival Nestle USA, is so much more than candy.
Virginia-based Mars on Sept. 12 announced its successful acquisition of VCA Inc. and its 800 small veterinary hospitals in the United States and Canada, its animal diagnostic imaging company and its doggy day care and overnight camp franchise, Camp Bow Wow. VCA has 15 locations in the Houston area and 54 across the state.
Mars, one of the nation's largest privately held companies, paid $93 per share for VCA (Nasdaq: WOOF) in a deal valued… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 13, 2017 Category: Biotechnology Authors: Michael Neibauer Source Type: news
Trio of KC animal hospitals (and 797 others) sell for $9.1B
Three Kansas City-area animal hospitals are now part of a very sweet conglomerate.
Mars Inc., based in McLean, Va., announced Tuesday its successful acquisition of VCA Inc. and its 800 small veterinary hospitals in the U.S. and Canada, its animal diagnostic imaging company and its doggy day care and overnight camp franchise, Camp Bow Wow.
Mars, one of the nation's largest priva tely held companies, paid $93 per share for VCA (NASDAQ: WOOF) in a deal valued at $9.1 billion. The acquisition was first… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 13, 2017 Category: Biotechnology Authors: Michael Neibauer Source Type: news
Trio of KC animal hospitals (and 797 others) sell for $9.1B
Three Kansas City-area animal hospitals are now part of a very sweet conglomerate.
Mars Inc., based in McLean, Va., announced Tuesday its successful acquisition of VCA Inc. and its 800 small veterinary hospitals in the U.S. and Canada, its animal diagnostic imaging company, and its doggy day care and overnight camp franchise, Camp Bow Wow.
Mars, one of the nation's largest priv ately held companies, paid $93 per share for VCA (NASDAQ: WOOF) in a deal valued at $9.1 billion. The acquisition was first… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 13, 2017 Category: American Health Authors: Michael Neibauer Source Type: news
Candy conglomerate Mars buys 800 animal hospitals for $9.1B, including handful in Central Texas
Mars Inc., like rival Nestle USA, is so much more than candy.
Mars on Tuesday announced its successful acquisition of VCA Inc. and its 800 small veterinary hospitals in the United States and Canada, its animal diagnostic imaging company and its doggy day care and overnight camp franchise, Camp Bow Wow. VCA has six locations in Austin and 54 across the state.
Mars, one of the nation's largest privately held companies, paid $93 per share for VCA (Nasdaq: WOOF) in a deal valued at $9.1 billion. The… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 13, 2017 Category: Biotechnology Authors: Michael Neibauer Source Type: news
